This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2020 Jun;50(6):e13258.

doi: 10.1111/eci.13258. Epub 2020 May 18.

QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine

Alice Monzani¹, Giulia Genoni², Alice Scopinaro³, Gianfranco Pistis³, Daniela Kozel³, Gioel Gabrio Secco³

Affiliations

Affiliations

¹ Division of Pediatrics, Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
² Neonatal and Pediatric Intensive Care Unit, Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy.
³ Department of Cardiology, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.

PMID: 32356580
PMCID: PMC7235515
DOI: 10.1111/eci.13258

QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine

Alice Monzani et al. Eur J Clin Invest. 2020 Jun.

. 2020 Jun;50(6):e13258.

doi: 10.1111/eci.13258. Epub 2020 May 18.

Authors

Alice Monzani¹, Giulia Genoni², Alice Scopinaro³, Gianfranco Pistis³, Daniela Kozel³, Gioel Gabrio Secco³

Affiliations

¹ Division of Pediatrics, Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.
² Neonatal and Pediatric Intensive Care Unit, Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy.
³ Department of Cardiology, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.

PMID: 32356580
PMCID: PMC7235515
DOI: 10.1111/eci.13258

No abstract available

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Cardiac toxicity related to chloroquine/hydroxychloroquine pathophysiology

Figure 2
Flow chart for QTc monitoring during hydroxychloroquine (HCQ) treatment in subjects with confirmed SARS‐CoV‐2 infection

See this image and copyright information in PMC

Similar articles

COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?
Javelot H, El-Hage W, Meyer G, Becker G, Michel B, Hingray C. Javelot H, et al. Br J Clin Pharmacol. 2020 Jun;86(6):1176-1177. doi: 10.1111/bcp.14335. Epub 2020 May 7. Br J Clin Pharmacol. 2020. PMID: 32350872 Free PMC article. No abstract available.
The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.
Chorin E, Dai M, Shulman E, Wadhwani L, Bar-Cohen R, Barbhaiya C, Aizer A, Holmes D, Bernstein S, Spinelli M, Park DS, Chinitz LA, Jankelson L. Chorin E, et al. Nat Med. 2020 Jun;26(6):808-809. doi: 10.1038/s41591-020-0888-2. Nat Med. 2020. PMID: 32488217 No abstract available.
QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin.
Hsia BC, Greige N, Quiroz JA, Khokhar AS, Daily J, Di Biase L, Ferrick KJ, Fisher JD, Krumerman A. Hsia BC, et al. J Interv Card Electrophysiol. 2020 Nov;59(2):337-345. doi: 10.1007/s10840-020-00822-x. Epub 2020 Jul 11. J Interv Card Electrophysiol. 2020. PMID: 32654098 Free PMC article.
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
Juurlink DN. Juurlink DN. CMAJ. 2020 Apr 27;192(17):E450-E453. doi: 10.1503/cmaj.200528. Epub 2020 Apr 8. CMAJ. 2020. PMID: 32269021 Free PMC article. Review. No abstract available.
Saudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19.
AlShoaibi NA, Maghrabi K, Alanazi H, Harbi MA, Alghamdi S. AlShoaibi NA, et al. Ann Saudi Med. 2020 Sep-Oct;40(5):365-372. doi: 10.5144/0256-4947.2020.365. Epub 2020 Oct 1. Ann Saudi Med. 2020. PMID: 32954790 Free PMC article. Review.

See all similar articles

Cited by

Concentration-dependent mortality of chloroquine in overdose.
Watson JA, Tarning J, Hoglund RM, Baud FJ, Megarbane B, Clemessy JL, White NJ. Watson JA, et al. Elife. 2020 Jul 8;9:e58631. doi: 10.7554/eLife.58631. Elife. 2020. PMID: 32639233 Free PMC article.
Changes in QTc interval after hydroxychloroquine therapy in patients with COVID-19 infection: a large, retrospective, multicentre cohort study.
El Kadri M, Al Falasi O, Ahmed R, Al Awadhi A, Altaha Z, Hillis A, Panikkaveetil B, Abdalla S, Ansel Benette H, Almubarak A, Saifuddin M, Alattar Y, Oulhaj A, AlKaabi S. El Kadri M, et al. BMJ Open. 2022 Feb 9;12(2):e051579. doi: 10.1136/bmjopen-2021-051579. BMJ Open. 2022. PMID: 35140148 Free PMC article.
Cardiovascular implications of the COVID-19: Management of complications and drug safety concerns.
Hamidian M, Ansari R, Zarshenas MM, Foroughinia F. Hamidian M, et al. J Res Med Sci. 2022 Dec 23;27:92. doi: 10.4103/jrms.jrms_895_21. eCollection 2022. J Res Med Sci. 2022. PMID: 36685029 Free PMC article. Review.
Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions.
Awortwe C, Cascorbi I. Awortwe C, et al. Pharmacol Res. 2020 Nov;161:105250. doi: 10.1016/j.phrs.2020.105250. Epub 2020 Oct 13. Pharmacol Res. 2020. PMID: 33059010 Free PMC article.
The potential role of SARS-CoV-2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread.
Alsaidan AA, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Alsayed KA, Saad HM, Batiha GE. Alsaidan AA, et al. Immun Inflamm Dis. 2023 Mar;11(3):e798. doi: 10.1002/iid3.798. Immun Inflamm Dis. 2023. PMID: 36988260 Free PMC article. Review.

See all "Cited by" articles

References

1. Zhou P, Yang X‐L, Wang X‐G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270‐273. - PMC - PubMed
1. WHO . Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. 2003. https://www.who.int/csr/sras/country/table2004_04_21/en. Accessed April 29, 2020.
1. WHO . Middle East respiratory syndrome coronavirus (MERS‐CoV), 2019. https://www.who.int/emergencies/mers‐cov/en. Accessed April 29, 2020.
1. Chan KS, Zheng JP, Mok YW, et al. SARS: prognosis, outcome and sequelae. Respirology. 2003;8(suppl):S36‐S40. - PMC - PubMed
1. Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS‐CoV): a systematic review and meta‐analysis. Int J Infect Dis. 2016;49:129‐133. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources